Literature DB >> 12004072

Polypyrimidine tract-binding proteins are cleaved by caspase-3 during apoptosis.

Sung Hoon Back1, Sejeong Shin, Sung Key Jang.   

Abstract

The polypyrimidine tract-binding protein (PTB), an RNA-binding protein, is required for efficient translation of some mRNAs containing internal ribosomal entry sites (IRESs). Here we provide evidence that the addition of apoptosis-inducing agents to cells results in the cleavage of PTB isoforms 1, 2, and 4 by caspase-3. This cleavage of PTB separated the N-terminal region, containing NLS-RRM1, from the C-terminal region, containing RRM2-3-4. Our data indicate that there are three noncanonical caspase-3 target sites in PTBs, namely Ile-Val-Pro-Asp(7)Ile, Leu-Tyr-Thr-Asp(139)Ser, and Ala-Ala-Val-Asp(172)Ala. The C-terminal PTB fragments localized to the cytoplasm, as opposed to the nucleus where most intact PTBs are found. Moreover, these C-terminal PTB fragments inhibited translation of polioviral mRNA, which contains an IRES element requiring PTB for its activation. This suggests that translation of some IRES-containing mRNAs is regulated by proteolytic cleavage of PTB during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004072     DOI: 10.1074/jbc.M203887200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  Identification of cellular proteins enhancing activities of internal ribosomal entry sites by competition with oligodeoxynucleotides.

Authors:  Kobong Choi; Jong Heon Kim; Xiaoyu Li; Ki Young Paek; Sang Hoon Ha; Sung Ho Ryu; Eckard Wimmer; Sung Key Jang
Journal:  Nucleic Acids Res       Date:  2004-02-23       Impact factor: 16.971

Review 3.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

Review 4.  Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.

Authors:  Amira Souii; Manel Ben M'hadheb-Gharbi; Jawhar Gharbi
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

5.  The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.

Authors:  Aishwarya G Jacob; Ravi K Singh; Fuad Mohammad; Thomas W Bebee; Dawn S Chandler
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

6.  A substrate-phage approach for investigating caspase specificity.

Authors:  Samantha Lien; Richard Pastor; Daniel Sutherlin; Henry B Lowman
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

7.  A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart.

Authors:  Junmei Ye; Miriam Llorian; Maria Cardona; Anthony Rongvaux; Rana S Moubarak; Joan X Comella; Rhonda Bassel-Duby; Richard A Flavell; Eric N Olson; Christopher W J Smith; Daniel Sanchis
Journal:  J Cell Sci       Date:  2013-02-19       Impact factor: 5.285

8.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

9.  Differential targeting of nuclear pore complex proteins in poliovirus-infected cells.

Authors:  Nogi Park; Pavan Katikaneni; Tim Skern; Kurt E Gustin
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

10.  Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.

Authors:  Gilbert J Cote; Wen Zhu; Anthony Thomas; Emil Martin; Ferid Murad; Iraida G Sharina
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.